GlassScriptPhysician profile
Joseph D Paz
NPI 1912907130
$745.84
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $125 · 2021: $123 · 2022: $43.51.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.21 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $115.28 | 2019-2020 | |
| Pacira Therapeutics, INC. | $108.44 | 2019 | |
| Biodelivery Sciences International, INC. | $57.55 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $49.53 | 2019 | |
| Medtronic USA, INC. | $40.66 | 2019-2020 | |
| Daiichi Sankyo INC. | $35.74 | 2019 | |
| Ferring Pharmaceuticals INC. | $28.71 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $25.10 | 2019 | |
| Nevro Corp. | $21.20 | 2020 | |
| Ibsa Pharma INC. | $17.15 | 2021 | |
| Si-Bone, INC. | $14.07 | 2019 | |
| Allergan, INC. | $13.06 | 2021 | |
| Medtronic, INC. | $12.89 | 2022 | |
| Kaleo, INC. | $12.85 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $12.77 | 2020 | |
| Shionogi INC | $12.24 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.81 | 2019 | |
| Pfizer INC. | $11.60 | 2019 | |
| Boston Scientific Corporation | $10.98 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Paz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.